BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Policy

  Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe

  Sandoz, the global leader in generic and biosimilar medicines, announced that the European Commission has granted marketing authorization for Wyost®1 and Jubbonti®2, the first and only biosimilar versions of reference medicines Xgeva®*3 and Prolia®*4 in Europe.

  May 22, 2024

   · 

  6 min read
• Pharm Country

  Arbutus to Present Imdusiran Data at EASL Congress 2024

  Arbutus Biopharma Corporation announced that two abstracts have been accepted for poster and oral presentations at the European Association for the Study of the Liver Congress 2024 taking place June 5 - 8, 2024 in Milan, Italy.

  May 22, 2024

   · 

  6 min read
• Business

  deepull appoints Didier Deltort to its Board of Directors

  deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis and other acute infections, announces the appointment of Didier Deltort to its Board of Directors.

  May 22, 2024

   · 

  2 min read
• Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients

  Royal Philips, a global leader in health technology, announced the successful nationwide rollout of its ambulatory cardiac monitoring service in Spain using its unique wearable ePatch paired with its AI-driven Cardiologs analytics platform.

  May 22, 2024

   · 

  5 min read
• Business

  G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses

  G1 Therapeutics, Inc., a commercial-stage oncology company, and Deimos Biosciences, a portfolio company of Jupiter Bioventures, announced a global licensing agreement for lerociclib for radioprotective uses.

  May 22, 2024

   · 

  5 min read
• IRLAB broadcasts the Annual General Meeting Live - May 22, 2024

  IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company’s annual general meeting will be broadcast live on YouTube.

  May 22, 2024

   · 

  1 min read
• Policy

  Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®

  Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces the agreed outcome of the “Day 100” meetingi with the US Food and Drug Administration, following receipt of the “Day 90” major deficiency Letter.

  May 22, 2024

   · 

  8 min read
• Business

  OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases

  OSE Immunotherapeutics SA and Boehringer Ingelheim announced a major expansion of their partnership.

  May 22, 2024

   · 

  9 min read
• Business

  Evotec Reports Q1 2024 Results and Provides Corporate Update

  Evotec SE announced financial results and corporate updates for the first quarter 2024.

  May 22, 2024

   · 

  14 min read
• Business

  NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update

  NANOBIOTIX provided an update on operational progress and reported financial results for the first quarter of 2024.

  May 22, 2024

   · 

  4 min read